| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $4.5M | $7.5M | $6.4M |
| YoY Revenue Growth % | -40.1% | +16.5% | — |
| Gross Profit | $129.8K | $1.3M | — |
| Gross Margin % | 2.9% | 17.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$19.4M | -$3.9M | -$3.9M |
| Operating Margin % | -80.0% | -51.6% | -60.4% |
| Net Income (GAAP) | -$19.3M | -$3.7M | -$3.5M |
| EBITDA (Normalized) | -$19.3M | -$3.8M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$2.4M | -$3.0M | -$3.2M |
| Capital Expenditures (CapEx) | $23.9K | $115.2K | — |
| Free Cash Flow (FCF) | -$2.5M | -$3.2M | -$3.2M |
| FCF Margin % | -54.6% | -42.1% | -49.1% |
| Return on Invested Capital (ROIC %) | -45.0% | -26.9% | — |
| Cash & Short-Term Equivalents | $645.9K | $1.3M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $4.9M | $12.6M | — |